FdaApplication

NDA 219745

Back to search

Identifiers

Properties

PropertyValue
applicant_nameACCORD BIOPHARMA INC
application_typeNDA
approval_date2025-08-25

Products (1)

ProductActive ingredientStrengthDosage form
CAMCEVI ETMLEUPROLIDE MESYLATEEQ 21MG BASEEMULSION;SUBCUTANEOUS

1 product